| |
| |
|
| Insider
Information: |
Blanchard Cheryl R |
| Relationship: |
Director |
| City: |
Warsaw |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
233,436 |
|
|
Indirect Shares
|
11,742 |
|
|
| Direct
Value |
$6,825,919 |
|
|
|
Indirect Value
|
$323,962 |
|
|
| Total
Shares |
245,178 |
|
|
| Total
Value |
$7,149,881 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 23.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Zimmer Holdings Inc |
ZBH |
Sr. VP, Chief Scientif... |
2012-03-16 |
18,357 |
2007-03-15 |
0 |
Premium* |
|
|
Seaspine Holdings Corp |
SPNE |
Director |
2018-05-30 |
28,948 |
2016-06-07 |
0 |
Premium* |
|
|
Anika Therapeutics Inc |
ANIK |
President, CEO, Direct... |
2024-03-11 |
151,694 |
2024-03-11 |
11,742 |
Premium* |
|
|
Neuronetics Inc |
STIM |
Director |
2020-05-26 |
34,437 |
2019-02-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ANIK |
Anika Therapeutics Inc |
President, CEO, Director |
• • – |
2024-03-11 |
4 |
D |
$25.42 |
$716,629 |
D/D |
(27,980) |
151,694 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
President, CEO, Director |
• • – |
2024-03-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
64,480 |
166,228 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
President, CEO, Director |
• • – |
2023-04-26 |
4 |
D |
$26.34 |
$287,106 |
D/D |
(10,900) |
114,255 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
President, CEO, Director |
• • – |
2023-04-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,575 |
125,155 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
President, CEO, Director |
• • – |
2023-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
30,060 |
113,791 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
President, CEO, Director |
• • – |
2023-03-10 |
4 |
D |
$26.10 |
$344,807 |
D/D |
(13,211) |
100,580 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
President, CEO, Director |
• • – |
2023-03-09 |
4 |
D |
$26.91 |
$113,883 |
D/D |
(4,232) |
83,731 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
President, CEO, Director |
• • – |
2023-03-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,419 |
87,963 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
President, CEO, Director |
• • – |
2022-04-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,576 |
72,826 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
President, CEO, Director |
• • – |
2022-03-11 |
4 |
B |
$25.36 |
$207,143 |
D/D |
8,100 |
59,992 |
2.81 |
% |
|
| ANIK |
Anika Therapeutics Inc |
President, CEO, Director |
• • – |
2022-03-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,420 |
51,892 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
President, CEO, Director |
• • – |
2021-06-15 |
4 |
OE |
$33.40 |
$100,000 |
D/D |
2,994 |
37,472 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
President, CEO, Director |
• • – |
2021-04-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,575 |
34,478 |
0 |
- |
|
| STIM |
Neuronetics Inc |
Director |
– • – |
2020-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
34,437 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
President, CEO, Director |
• • – |
2020-04-26 |
4 |
D |
$33.40 |
$59,920 |
D/D |
(1,794) |
9,903 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
President, CEO, Director |
• • – |
2020-04-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,231 |
11,697 |
0 |
- |
|
| STIM |
Neuronetics Inc |
Director |
– • – |
2019-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
3,723 |
4,437 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
Director |
– • – |
2019-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
3,842 |
7,466 |
0 |
- |
|
| STIM |
Neuronetics Inc |
Director |
– • – |
2019-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
714 |
714 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
Director |
– • – |
2018-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,624 |
3,624 |
0 |
- |
|
| SPNE |
Seaspine Holdings Corp |
Director |
– • – |
2018-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,857 |
28,948 |
0 |
- |
|
| SPNE |
Seaspine Holdings Corp |
Director |
– • – |
2017-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
10,081 |
20,091 |
0 |
- |
|
| SPNE |
Seaspine Holdings Corp |
Director |
– • – |
2016-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
10,010 |
10,010 |
0 |
- |
|
| ZBH |
Zimmer Holdings Inc |
Sr. VP, Chief Scientific Off. |
• – – |
2012-03-16 |
4 |
D |
$63.94 |
$86,191 |
D/D |
(1,348) |
18,357 |
0 |
- |
|
| ZBH |
Zimmer Holdings Inc |
Sr. VP, Chief Scientific Off. |
• – – |
2012-03-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,368 |
19,705 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
